Galen Partners is a leading healthcare growth equity firm that focuses on investments in healthcare technology-enabled services, medical devices and specialty pharmaceutical companies. Galen has invested nearly $1 billion in more than 70 companies since 1990. The firm leads investments of $10 million to $30 million of growth equity capital. Galen continues its tradition of strategic collaboration and active partnership with its portfolio company management teams to build healthcare market leaders.
Our News page includes News Articles and Press Releases corresponding to both Galen and its portfolio companies.
Galen focuses on companies with proprietary products and services. We invest within three key areas of healthcare: Galen focuses on healthcare-related companies with proprietary products and services. Investing healthcare growth equity within three key areas: